Chemours Co (CC) Income Tax Expense (Benefit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Chemours Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2024.
  • Chemours Co Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $15 M, a 46.4% decline year-over-year.
  • Chemours Co Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$94 M, a 165% decline year-over-year.
  • Chemours Co annual Income Tax Expense (Benefit) for 2023 was -$81 M, a 150% decline from 2022.
  • Chemours Co annual Income Tax Expense (Benefit) for 2022 was $163 M, a 140% increase from 2021.
  • Chemours Co annual Income Tax Expense (Benefit) for 2021 was $68 M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$94 M $15 M -$13 M -46.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 -$81 M -$53 M -$81 M -289% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $0 $1 M -$58 M -98.3% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-27
Q2 2023 $58 M -$57 M -$87 M -290% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $145 M $28 M -$18 M -39.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $163 M $28 M -$40 M -58.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $203 M $59 M +$42 M +247% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $161 M $30 M +$52 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $109 M $46 M +$41 M +820% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $68 M $68 M +$65 M +2167% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 $3 M $17 M +$33 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$30 M -$22 M -$18 M -450% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 -$12 M $5 M +$28 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$40 M $3 M +$140 M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 -$180 M -$16 M -$31 M -207% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$149 M -$4 M -$41 M -111% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$108 M -$23 M -$36 M -277% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$72 M -$137 M -$177 M -443% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $105 M $15 M +$21 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $84 M $37 M -$4 M -9.76% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $88 M $13 M -$71 M -84.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $159 M $40 M +$4 M +11.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $155 M -$6 M -$49 M -114% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $204 M $41 M -$23 M -35.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $227 M $84 M +$62 M +282% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $165 M $36 M +$80 M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $85 M $43 M +$13 M +43.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $72 M $64 M +$87 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$15 M $22 M +$3 M +15.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$18 M -$44 M -$9 M -25.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 -$9 M $30 M +$108 M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$117 M -$23 M -$23 M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$94 M $19 M +$4 M +26.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$98 M -$35 M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 -$78 M -$113 M -323% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $0 -$39 M -100% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $15 M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 $35 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $39 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.